NCT00007995View on ClinicalTrials.gov

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

November 30, 2007

Study Completion Date

May 31, 2008

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

sargramostim

DRUG

busulfan

DRUG

cyclophosphamide

DRUG

melphalan

PROCEDURE

autologous bone marrow transplantation

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Herbert Irving Comprehensive Cancer Center

OTHER

NCT00007995 - Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | Biotech Hunter | Biotech Hunter